Study sexual side effects in schizophrenia with diabetes
Part of Hormones & metabolism, Mental health clinical trials.
This study looks at how sexual functioning is affected in people with schizophrenia, especially in those who also have diabetes or weight-related risk. It also examines how psychiatric medicines and diabetes/weight factors may be connected, which could help improve care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a schizophrenia-spectrum diagnosis
- You have diabetes, or past/present prediabetes on blood tests, or a BMI of 30 or higher
- You are currently taking at least one antipsychotic medicine (for example, pills or injections)
- You can complete a sex-function questionnaire called CSFQ-14
- You can speak and understand Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special clinic that helps people with schizophrenia or bipolar disorder manage their weight and metabolic health while taking antipsychotic medication. It focuses on improving overall health with practical support.
This study tests whether bromocriptine, a medication that may improve blood sugar control, can help people with schizophrenia who have prediabetes. If you qualify, you might receive the drug or a placebo to see if it helps prevent diabetes.
This trial tests whether metformin can help prevent or manage blood sugar problems that may arise when people with schizophrenia take statins (cholesterol-lowering drugs). If you have schizophrenia, are on a stable medication routine, and have high cholesterol but not diabetes, this study might be an option.
This study looks at how immune system health relates to brain changes in people with schizophrenia. It uses brain imaging and electrical activity tests to understand these connections.
This study examines how emotional eating, sleep quality, and mental state relate to metabolic syndrome (a group of conditions like high blood pressure, high blood sugar, and extra belly fat) in people with stable schizophrenia or bipolar disorder. It aims to help understand and improve overall health.
This study uses PET and MRI scans to see how antipsychotic medications affect the brain's dopamine system in people with schizophrenia, compared to healthy individuals. It may help understand if these medications cause changes that lead to worsening symptoms over time.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.